KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Total Current Liabilities (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 17 years of Total Current Liabilities data on record, last reported at $903.5 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 196.64% year-over-year to $903.5 million; the TTM value through Sep 2025 reached $903.5 million, up 196.64%, while the annual FY2024 figure was $309.3 million, 30.97% down from the prior year.
  • Total Current Liabilities reached $903.5 million in Q3 2025 per IONS's latest filing, up from $897.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $903.5 million in Q3 2025 and bottomed at $228.4 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $363.1 million, with a median of $295.1 million recorded in 2021.
  • Peak YoY movement for Total Current Liabilities: plummeted 59.83% in 2021, then skyrocketed 196.64% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $240.6 million in 2021, then increased by 29.52% to $311.6 million in 2022, then soared by 43.82% to $448.1 million in 2023, then plummeted by 30.97% to $309.3 million in 2024, then surged by 192.08% to $903.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $903.5 million in Q3 2025, $897.2 million in Q2 2025, and $250.3 million in Q1 2025.